Congratulations to fellow surgeon, collaborator & friend ⁦Joseph Califano UCSD Cancer⁩ for his appointment as Cancer Center Director ⁦⁦UC San Diego Health. I look forward to continuing our work together to develop less toxic & more effective therapies for patients. health.ucsd.edu/news/releases/…

Since 2011 there has been MASSIVE lung cancer overdiagnosis (particularly in women) in China since the introduction of Low-Dose CT Imaging. See CHEST® Journal article here: sciencedirect.com/science/articl…

#RCSICharter Meeting has got off to a great start! You can still register for events taking place later this week including the 98th Abraham Colles Lecture delivered by Dr Luc Morris from Memorial Sloan Kettering Cancer Center. #CPD available for all sessions. Join us ➡️rcsi.com/dublin/news-an…

A superb #RCSICharter ORL-HNS session brought to a close by Lực Morris from @MSKcancercentre providing a world class update on immune surveillance in HNSCC RCSI

President Viani RCSI introduces Professor Lực Morris, Memorial Sloan Kettering Cancer Center, to give an outstanding 98th Abraham Colles Lecture #RCSICharter with a thought-provoking caution on 'The Cobra Effect' in cancer diagnosis & management. 'Don't just do something, stand there'

1. ENTER #mRNAvaccines for #pancreaticcancer! Long-term #PDAC survivor story PART3. "Do #PDACs REALLY have vaccine neoantigens (NAs)"? (aren’t they lowly mutated?) If each patient = own NAs, how do you vaccinate? Maybe mRNA? But how? nature nature.com/articles/s4158… 👇🏽 [1/32]

Amazing data from Adamson & colleagues showing melanoma in situ assoc w/ longer survival than non-MIS counterparts, due to healthy user (“healthy screenee”) effect. Diagnosis with MIS is a marker of being health conscious/good access to healthcare, not a risk factor for death!

Harmless cancers are being overdiagnosed & overtreated in America. In my latest Fortune, multiple experts share their recs.tinyurl.com/4bzfnhd3 Thank you to @DrLauraEsserman Rita Redberg UCSF Health Lực Morris Memorial Sloan Kettering Cancer Center Shelley Hwang Ade Adamson, MD MPP #CancerAwareness

The growing case for doing less: How harmless cancers are being overdiagnosed in America bit.ly/3RF1VeL during October's pinkification we rarely discuss the downside to screening. #BreastCancerAwarenessMonth #overdiagnosis

Common cancer screens (mammography, colonoscopy, PSA testing, etc.) don't save lives by extending lifetimes, per a meta-analysis of over 2M ppl. That's pretty shocking when you think about it. And for too many Americans, the downstream effects of mass screening (biopsies,

1/ 🌟 Thrilled to share our latest #MachineLearning work in #immunotherapy, published in Nature Cancer! Explore our findings here: doi.org/10.1038/s43018…

🚨📢Happening now - HN oral abstracts #ASCO24‼️ PRACTICE CHANGING trial of hypoxia directed major radiation de-escalation as definitive treatment for HPV+OPC by Nancy Lee Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center, showing that 30Gy+Chemo is sufficient for cure, with > 500 pts treated so far.

LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features ⁦Nature Cancer⁩ ⁦Lực Morris⁩ @NCIEytanRuppin⁩ nature.com/articles/s4301…

A very thoughtful opinion piece by Nancy Lee Memorial Sloan Kettering Radiation Oncology Lực Morris Max Diehn, MD/PhD outlining the caveats of using TTMV-HPV DNA as a routine biomarker for surveillance and treatment decision-making. Given the lack of robust sensitivity, such application should be carried out in

thanks and I am glad to hear this! The SSMI hiccup remedy: not quite 100% effective but almost... But our publications are old, and sample sizes too small. Maybe time for a large crowdsourced online randomized trial! David Ziff Jennifer Marti MD Uri Bram 🔍

#FCS2024 Thanks Gopal Iyer for the invitation to speak on #Radioresistance #Radiotherapy to share our work on novel pathways of #Radiorecurrence Great chance to catch up with Edward Chow Lực Morris from 🇺🇸 We need more of these in #Asia AACR Lillian Siu Margaret Foti, PhD, MD (hc)

From JAMA Otolaryngology – Head & Neck Surgery: Among patients with papillary thyroid cancer who choose active surveillance, those who eventually go on to surgery achieve results comparable to those who choose immediate surgery. ja.ma/41t1yJa Helena Levyn Lực Morris Memorial Sloan Kettering Cancer Center

Researchers co-led by Lực Morris from 🇺🇸 Memorial Sloan Kettering Cancer Center and 🇺🇸 The Tisch Cancer Institute have developed an #AI-based model to better predict whether #cancer patients will benefit from #immunotherapy — using only routine 🩸 blood tests and clinical data. dlvr.it/THJhSS

Very happy to see the Research Briefing in Nature Medicine on SCORPIO! SCORPIO was created to democratize precision oncology, overcoming the limited access to genomic testing worldwide. Read more: nature.com/articles/s4159…

#mRNAvaccines for #PancreaticCancer (PDAC) PART4 1. Out today in nature nature.com/articles/s4158… 🧵👇🏽 [1/23]